Zurueck zur Suche

Reporte zur Charge EJ8762

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 1

VAERS 1995388

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EJ8762

schwer
Staat
NY
Alter
54,0
Geschlecht
F
Eingang
31.12.2021
Impfdatum
02.12.2021
Beginn
02.12.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest pain Dyspnoea Heart rate Heart rate irregular Immunisation Joint swelling Myocarditis Pyrexia SARS-CoV-2 test Tachycardia

Symptomtext

Most of the symptoms of Myocarditis; Irregular heart rates; Tachycardia; SOB with no exertion; Fever spikes; Chest pain; Ankle swelling; Dose received 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 54 year-old female patient (not pregnant) received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE), administered in arm left, administration date 02Dec2021 10:00 (Lot number: EJ8762) at the age of 54 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Congenital Heart Disease" (unspecified if ongoing), notes: (take Lasix, Toprol, Lisinopril for Congenital Heart Disease); "Post Acute Covid Syndrome" (unspecified if ongoing); "Risks for Heart Disease" (unspecified if ongoing); "s/p childhood heart surgery" (unspecified if ongoing); "Severe apnea (treated)" (unspecified if ongoing); "SVT" (unspecified if ongoing); "Known allergies: Only seasonal allergies" (unspecified if ongoing); "COVID Alpha variant", start date: Nov2020 (unspecified if ongoing); "POTS" (unspecified if ongoing); "Autonomic Dysfunction" (unspecified if ongoing); "pulmonary rehab" (unspecified if ongoing). Concomitant medication(s) included: LASIX [FUROSEMIDE] taken for heart disease congenital (ongoing); TOPROL taken for heart disease congenital (ongoing); LISINOPRIL [LISINOPRIL DIHYDRATE] taken for heart disease congenital (ongoing). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EP7533, Location of injection: Arm Left), administration date: 03Apr2021, when the patient was 54 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, lot number: EN 6204, Location of injection: Arm Left, administered on 06Dec2021 (as reported)), for COVID-19 immunization. The following information was reported: IMMUNISATION (medically significant) with onset 02Dec2021, outcome "unknown", described as "Dose received 3"; MYOCARDITIS (medically significant) with onset 09Dec2021, outcome "not recovered", described as "Most of the symptoms of Myocarditis"; HEART RATE IRREGULAR (medically significant) with onset 09Dec2021, outcome "not recovered", described as "Irregular heart rates"; TACHYCARDIA (medically significant) with onset 09Dec2021, outcome "not recovered", described as "Tachycardia"; DYSPNOEA (medically significant) with onset 09Dec2021, outcome "not recovered", described as "SOB with no exertion"; PYREXIA (medically significant) with onset 09Dec2021, outcome "not recovered", described as "Fever spikes"; CHEST PAIN (non-serious) with onset 09Dec2021, outcome "not recovered", described as "Chest pain"; JOINT SWELLING (non-serious) with onset 09Dec2021, outcome "not recovered", described as "Ankle swelling". The events "most of the symptoms of myocarditis", "irregular heart rates", "tachycardia", "sob with no exertion", "fever spikes", "chest pain" and "ankle swelling" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: heart rate: (09Dec2021) irregular; sars-cov-2 test: (15Dec2021) negative, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of myocarditis, heart rate irregular, tachycardia, dyspnoea, pyrexia, chest pain, joint swelling. Clinical course: Patient was a Covid Long Hauler. Patient was diagnosed with Alpha variant in Nov2020, before any treatments or Vaccines existed. Patient was still symptomatic with Autonomic Dysfunction and symptoms of POTS (Postural orthostatic tachycardia syndrome). After the 3rd vaccine, patient felt "cured" for one week- then "crashed." Patient presumed that she was having a Long Covid relapse, but later discovered that she had most of the symptoms of Myocarditis. Irregular heart rates, tachycardia, SOB (shortness of breath) with no exertion, fever spikes- all Myocarditis symptoms except for Chest pain or ankle swelling (Patient takes LASIX, TOPROL, Lisinopril for Congenital Heart Disease). It was only today that he/she reached out to his/her MD and Cardiologist. Symptoms began 09Dec2021. Patient has missed 5 days of daily pulmonary rehab. If her symptoms continue, patient will try to get an EKG, CXR and labs on 18Dec2021. Patient called 2 doctors but could not be seen on 17Dec2021. Patient has also requested a heart monitor to wear at home from her Cardiologist. Events were reported as non-serious, results in death: no, seriousness criteria-life threatening: no, prolonged hospitalization: no, disabling/incapacitating: no, congenital anomaly/birth defect: no. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
Test Date: 20211209; Test Name: heart rates; Result Unstructured Data: Test Result:Irregular; Test Date: 20211215; Test Name: Binax Now; Test Result: Negative ; Comments: Nasal Swab
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Apnea; Autonomic dysfunction; Cardiac operation; COVID-19; Heart disease congenital ((take Lasix, Toprol, Lisinopril for Congenital Heart Disease)); Heart disorder; Postural orthostatic tachycardia syndrome; Rehabilitation therapy; Seasonal allergy; Supraventricular tachycardia
Andere Medikamente
LASIX [FUROSEMIDE]; TOPROL; LISINOPRIL [LISINOPRIL DIHYDRATE]
Allergien
-
Vorherige Impfungen
-

VAERS 2666951

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EJ8762

gering
Staat
-
Alter
38,0
Geschlecht
F
Eingang
07.08.2023
Impfdatum
23.02.2022
Beginn
29.03.2022
Tage bis Beginn
34,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Chronic respiratory failure Epilepsy Respiratory failure

Symptomtext

EPILEPSY, UNSPECIFIED CHRONIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chronic respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-